Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identifying predictive factors in melanoma progression

D M Dabrowska1, R M Elashoff, W Ho

  • 1Department of Biostatistics, University of California, 10833 Le Conte Avenue, Los Angeles, CA, 90095-1772, USA.

Oncology Reports
|May 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer.

Seminars in oncology·2001
Same author

Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.

CA: a cancer journal for clinicians·2001
Same author

Immunology of gangliosides.

Indian journal of experimental biology·2001
Same author

Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2000

This study identifies key melanoma progression risk factors using a multistate model. Age, male gender, tumor invasion depth, and invasion level increase melanoma progression risk, while extremity location decreases it.

Area of Science:

  • Oncology
  • Biostatistics
  • Dermatology

Background:

  • Melanoma progression understanding relies on limited two-stage models.
  • Accurate identification of prognostic factors is crucial for melanoma research.
  • Existing models do not fully capture complex interactions between risk factors.

Purpose of the Study:

  • To identify prognostic factors for melanoma progression using a multistate Markov chain model.
  • To investigate novel interactions among prognostic factors in melanoma.
  • To refine understanding of melanoma disease trajectory and risk stratification.

Main Methods:

  • Applied a multistate Markov chain process with Cox proportional hazard regression.
  • Analyzed data from 3,434 patients with AJCC stage I or II melanoma.

Related Experiment Videos

  • Utilized survival probability plots to supplement parameter estimates.

    • Main Results:

    • Age and male gender increase progression risk; tumor location on extremities decreases it.
    • Higher Clark's level and Breslow's depth elevate progression risk.
    • Identified novel interactions: age-gender (I/II to III), level-depth (I/II to III), site-gender (I/II to III, III to IV, IV to death), and primary site (IV to death).

    Conclusions:

    • Multistate modeling effectively identifies melanoma prognostic factors and their interactions.
    • Established prognostic factors like age, gender, invasion depth, and tumor site significantly influence melanoma progression.
    • This research introduces new insights into the complex interplay of factors driving melanoma advancement, particularly highlighting previously unidentified interactions.